Skip to content
Screener

CareDx CDNA Finite-Lived Intangible Assets, Accumulated Amortization

Finite-Lived Intangible Assets, Accumulated Amortization at other companies

Natera, Inc. logo
Natera, Inc.NTRA
$19.17M
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
$990.7M+21.3%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
NeoGenomics logo
NeoGenomicsNEO
Guardant Health logo
Guardant HealthGH
GeneDx Holdings logo
GeneDx HoldingsWGS

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$2.42B+279%
Enterprise value$2.36B+295%
P/S5.9×+4.0×

Profitability

See full
Gross margin65.5%
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.

The source filing: CareDx’s 10-Q, filed April 28, 2026.

Filed
Apr 28, 2026, 4:13 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001217234-26-000033
Line itemGross Carrying AmountAccumulated AmortizationForeign Currency TranslationNet Carrying AmountWeighted Average Remaining Useful Life(In Years)
Customer relationships25,581(12,864)(1,769)10,9486.9
Commercialization rights11,579(7,338)4,2413.3
Trademarks and tradenames4,860(2,529)(255)2,0766.4
Total intangible assets with finite lives80,599(47,641)(4,349)28,609
Intangible assets with indefinite lives:
Acquired in-process technology1,2501,250
Favorable license agreement2,2432,243
Total intangible assets with indefinite lives3,4933,493

ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FAQ

What is CareDx's finite-lived intangible assets, accumulated amortization?
CareDx (CDNA) reported finite-lived intangible assets, accumulated amortization of $47.64M in Q1 2026.
How has CareDx's finite-lived intangible assets, accumulated amortization changed year-over-year?
CareDx's finite-lived intangible assets, accumulated amortization increased by 14.7% year-over-year, from $41.53M to $47.64M.
What is the long-term trend for CareDx's finite-lived intangible assets, accumulated amortization?
Over 5 years (2020 to 2025), CareDx's finite-lived intangible assets, accumulated amortization has grown at a 24.3% compound annual growth rate (CAGR), from $15.52M to $46M.

Ask your AI about CareDx's finite-lived intangible assets, accumulated amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude